DANIEL BRANZBURG: Open Payments
NPI 1992416267 · WELLSBORO, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 12 payments from 8 companies in 2025. Trend: 2023 $201 · 2024 $240 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Lilly USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $14 |
Products named: CAPLYTA, MOUNJARO, PURIFIED CORTROPHIN GEL, Dexcom G6 Transmitter, Wegovy, VOQUEZNA, BREZTRI, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
